What's New on the FDA Drugs Site
August 13, 2015
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- National Drug Code Directory
New and Generic Drug Approvals
August 12, 2015
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Acetaminophen | acetaminophen | Suppository;Rectal | Taro Pharms North | Labeling Revision |
| Envarsus Xr | tacrolimus | Tablet, Extended Release;Oral | Veloxis Pharma Inc | Labeling Revision |
| Infants' Feverall | acetaminophen | Suppository;Rectal | Taro Pharms North | Labeling Revision |
| Levofloxacin | levofloxacin | Injectable; Injection | Hospira Inc | Approval |
| Sprycel | dasatinib | Tablet;Oral | Bristol Myers Squibb | Efficacy Supplement with Clinical Data to Support |
| Sprycel | dasatinib | Tablet;Oral | Bristol Myers Squibb | Labeling Revision |
| This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
—
Friday, August 14, 2015
—
Add Comment
Belum ada tanggapan untuk "CDER New August 14, 2015"
Post a Comment